May 16, 2018
PET tracer may predict response to therapy in bone-dominant breast cancer patients
A prospective comparison study of two PET tracers found 18F-FDG could provide valuable measures of activity in bone-dominant (BD) metastatic breast cancer (MBC) patients, while also predicting responses to therapy. {read more here}